{
  "success": true,
  "enriched": 36,
  "total_entities": 743,
  "by_type": {
    "StudyArm": 1,
    "EligibilityCriterion": 21,
    "Objective": 4,
    "Endpoint": 10
  },
  "enriched_items": [
    {
      "type": "StudyArm",
      "name": "Ontamalimab 75 mg",
      "arm_type": "Experimental Arm",
      "nci_code": "C174266"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Willingness and ability to comply",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Informed consent",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Age requirement",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Signs of fibrogenic activity",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "NASH indication via biopsy",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Contraception requirements",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Breastfeeding restriction",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "AST and ALT levels exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Laboratory findings exclusion at SV1 or ",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Decompensated liver disease",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Other causes of liver disease",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Impaired hemostasis",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Significant concurrent medical condition",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Severe active inflammatory bowel disease",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Severe immune-mediated inflammatory dise",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Body weight change",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Laboratory abnormality affecting safety ",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Hypersensitivity to ontamalimab",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Active or latent tuberculosis infection",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Abnormal chest X-ray findings",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Positive IGRA at screening",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "Objective",
      "name": "Primary Safety Objective",
      "level": "Trial Primary Objective",
      "nci_code": "C85826"
    },
    {
      "type": "Objective",
      "name": "Secondary Biomarker Objective",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Objective",
      "name": "Exploratory Biomarker Objective",
      "level": "Trial Exploratory Objective",
      "nci_code": "C163559"
    },
    {
      "type": "Objective",
      "name": "Pharmacokinetic Objective",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Endpoint",
      "name": "Treatment-Emergent Adverse Events",
      "level": "Primary Outcome Measure",
      "nci_code": "C98772"
    },
    {
      "type": "Endpoint",
      "name": "Serious Adverse Events",
      "level": "Primary Outcome Measure",
      "nci_code": "C98772"
    },
    {
      "type": "Endpoint",
      "name": "Clinical Laboratory Tests",
      "level": "Primary Outcome Measure",
      "nci_code": "C98772"
    },
    {
      "type": "Endpoint",
      "name": "Vital Signs",
      "level": "Primary Outcome Measure",
      "nci_code": "C98772"
    },
    {
      "type": "Endpoint",
      "name": "ECG Findings",
      "level": "Primary Outcome Measure",
      "nci_code": "C98772"
    },
    {
      "type": "Endpoint",
      "name": "Pro-C3 Change from Baseline",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "ELF Change from Baseline",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "cT1 MRI Change from Baseline",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Exploratory Biomarkers and Noninvasive Tests",
      "level": "Exploratory Outcome Measure",
      "nci_code": "C98724"
    },
    {
      "type": "Endpoint",
      "name": "Pharmacokinetic Concentrations",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    }
  ],
  "cache_stats": {
    "total_entries": 50,
    "fresh_entries": 50,
    "stale_entries": 0,
    "cache_file": "C:\\Users\\panik\\Documents\\GitHub\\Protcol2USDMv3\\core\\evs_cache\\nci_codes.json"
  }
}